View : 757 Download: 0
Single mucosal vaccination targeting nucleoprotein provides broad protection against two lineages of influenza B virus
- Title
- Single mucosal vaccination targeting nucleoprotein provides broad protection against two lineages of influenza B virus
- Authors
- Kim, Myung Hee; Kang, Jung-Ok; Kim, Joo-Young; Jun, Hi Eun; Lee, Heung Kyu; Chang, Jun
- Ewha Authors
- 장준
- SCOPUS Author ID
- 장준
- Issue Date
- 2019
- Journal Title
- ANTIVIRAL RESEARCH
- ISSN
- 0166-3542
1872-9096
- Citation
- ANTIVIRAL RESEARCH vol. 163, pp. 19 - 28
- Keywords
- Influenza B virus; Vaccine; Nucleoprotein; Mucosal immunization; Protection
- Publisher
- ELSEVIER SCIENCE BV
- Indexed
- SCIE; SCOPUS
- Document Type
- Article
- Abstract
- Nucleoprotein is highly conserved among each type of influenza viruses (A and B) and has received significant attention as a good target for universal influenza vaccine. In this study, we determined whether a recombinant adenovirus encoding nucleoprotein of type B influenza virus (rAd/B-NP) confers protection against influenza virus infection in mice. We also identified a cytotoxic T lymphocyte epitope in the nucleoprotein to determine B-NP-specific CD8 T-cell responses. We found that B-NP-specific CD8 T cells induced by rAd/B-NP immunization played a major role in protection following influenza B virus infection using CD8 knockout mice. To assess the effects of the administration routes on protective immunity, we immunized mice with rAd/B-NP via intranasal or intramuscular routes. Both groups showed strong NP-specific humoral and CD8 T-cell responses, but only intranasal immunization provided complete protection against both lineages of influenza B virus challenge. Intranasal but not intramuscular administration established resident memory CD8 T cells in the airway and lung parenchyma, which were required for efficient protection. Furthermore, rAd/B-NP in combination with rAd/A-NP protected mice against lethal infection with both influenza A and B viruses. These findings demonstrate that rAd/B-NP could be further developed as a universal vaccine against influenza.
- DOI
- 10.1016/j.antiviral.2019.01.002
- Appears in Collections:
- 약학대학 > 약학과 > Journal papers
- Files in This Item:
There are no files associated with this item.
- Export
- RIS (EndNote)
- XLS (Excel)
- XML